Research
Funded/In Review Grant Activity
Ongoing Support
Schenkman M (PI). Davis Phinney Foundation 07/01/16-06/30/18
A novel approach to fatigue in Parkinson’s disease. This cross sectional investigation examines the contributions of visual, vestibular and oculomotor deficits to fatigue in those living with Parkinson’s disease. ($42,000)
Completed Support
Schenkman M (PI). Project Sparx ($10,000). 03/01/15-03/01/17
Fatigue in Parkinson’s Disease: The Contribution of Visual, Vestibular, and Oculomotor Deficits.
Hebert JR, Schenkman M (Co-PI) National MS Society 10/01/12- 09/30/15
This randomized clinical trial is designed to examine the impact of vision and balance training on fatigue and postural control of individuals with multiple sclerosis. ($536,295.00 direct over three years)
Schenkman M, Corcos D (Co-PIs) R01 NS074343-01A1 12/1/2011 – 11/30/2015
Exploratory study of different doses of endurance exercise in people with Parkinson’s disease. ($2.930 million). This phase II randomized clinical trial is designed to determine parameters of exercise intensity that attenuate progression of symptoms of PD. Upon the completion of this study we will have defined the needed parameters for a phase III clinical trial.
Stevens-Lapsley J (PI) NIH R01-HD065900 07/1/2011-6/30/16
Progressive Rehabilitation for Total Knee Arthroplasty. The major goal of this project is to evaluate the effectiveness of a more intensive rehabilitation program compared to traditional rehabilitation after total knee arthroplasty.
Role: Co-I
Schenkman M (PI): NIH3 - R01 HD043770-05S2 (2010-2011) no cost extension.
Moss M (PI), Quon D, Nordon-Craft, A, Schenkman M. The diagnosis and treatment of critical care polyneuromyopathy. NIH.NRO1-1051-01A1, 2009-2014. (2.279 million direct over five years). Determine whether critical care illness can be identified early and determine the impact of an impact of intensive physical intervention for people with acute respiratory failure who have developed polyneuromyopathy. (Role: Co-I)
Schenkman M (PI), Hebert J, Corboy J. The effects of vestibular rehabilitation on MS-related fatigue: randomized control trial. National Multiple Sclerosis Society, February 2008-December 31, 2009. ($43,774). RCT that examines the benefits of vestibular exercise for people with PD.
Schenkman M (PI): Exercise from the perspective of the person who lives with Parkinson’s disease. Davis Phinney Foundation ($59,186) this qualitative study explored the experience and perspectives of graduates from a 16-month exercise intervention study a year or more after graduation. (July 2016-June 2018)
Schenkman M (PI), Baron A, Kohrt W, Kumar R, Schwartz R. Exercise, physical function, and Parkinson’s disease. NIH.HD43770, 2003-2008; no cost extension through 2011. ($1.125 million direct over five years). RCT comparing three exercise approaches for people with PD.
Schenkman M (PI). Comparison of three exercise interventions for people with recurrent low back pain. Physical Therapy Foundation, 2001. ($40,000).
Taylor D (PI), Schenkman M (Co-I), Sloan F. Economic burden of Alzheimer’s disease. AARP Andrus Foundation, 1999. ($75,000).
Schenkman M (PI), Whetten-Goldstein K. Holistic burden of Parkinson's disease. Duke University Medical Center Small Grant, 1997-1998. ($7,500).
Cutson T (PI), Schenkman M (co-investigator). Reliability and validity of a rating scale by persons with Parkinson's disease. Claude D Pepper OAIC Research and Development Funds, 1993-1994. ($8,000).
Cohen HJ (Director), Schenkman M (Co-Director). Center grant from Claude D Pepper Older American Independence Center. National Institute of Aging, 1992-1997. ($6.2 million).
Schenkman M (PI), Duncan PW, Chandler JC. Axial mobility and Parkinson's disease (Part of the Claude D Pepper Older Americans Independence Center). National Institute of Aging, 1992-1997. ($191,075).
Lyles K (PI), Schenkman M (Co-PI). Research Development Core (Part of the Claude D Pepper Older Americans Independence Center). National Institute of Aging, 1992-1997. ($875,998).
Schenkman M (PI). Relationship between axial mobility and functional performance. Duke University Medical Center Small Grant, 1992-1993. ($7,241).
Studenski S (PI), Duncan PW, Chandler J, Schenkman M. Do changes in strength improve balance in elderly men? Veterans Administration R & D, 1991-1994. ($345,000).
Schenkman M (PI). Balance and functional performance of individuals with Parkinson's disease. The Foundation for Physical Therapy, 1990. ($23,780).
Publications and Presentations
Scholarly Agenda
Clinical reasoning for physical therapist practice
Physical interventions for people with neurological dysfunction
Epigenetics and physiological impact of Heartfulness meditation
Within the last five years
Peer Reviewed Publications
Prohaska C, Sottile PD, Nordon-Craft A, Gallagher M, Burnham EL, Clark BJ, Ho M, Tyree M, Kiser T, Vandivier RW, Liu W, Schenkman M, Moss M. Patterns of Utilization and Effects of Hospital-Specific Factors on Physical, Occupational and Speech Therapy for Critically Ill Patients with Acute Respiratory Failure in the United States: Results of a Five Year Sample Critical Care (Accepted for publication).
Mañago MM, Cameron M, Schenkman M. Association of the Dynamic Gait Index to fall history and muscle function in people with multiple sclerosis: A secondary data analysis. Disability and Rehabilitation. 2019: Epub ahead of print. doi:10.1080/09638288.2019.1607912.
McManus BM, Richardson Z, Schenkman M, Murphey M, Morrato EH. Timing and intensity of early intervention service use and outcomes among a safety-net population of children. JAMA Network Open. 2019;2(1):e187529. doi:10.1001/jamanetworkopen.2018.7529
Berliner JM, Kluger B, Corcos DM, Pelak V, Gisbert R, McRae C, Atkinson K, Schenkman M. Patient perceptions of visual, vestibular, and oculomotor deficits in people with Parkinson’s disease. Physiotherapy Theory and Practice. In press
Christiansen CL, Miller MJ, Murray AM, Stephenson RO, Stevens-Lapsley JE, Hiatt WR, Schenkman ML. Behavior-change intervention targeting functional capacity, walking activity, and disability after dysvascular amputation: A randomized controlled pilot trial. Archives Phys Med Rehabil. I 2018;99:2160-2167. doi: 10.1016/j.apmr.2018.04.011. Epub 2018 May 7.PMID:29746823
Hall DA, Moore C, Comella C, SPARX STUDY GROUP. Recruitment of patients with de novo Parkinson disease: Successful strategies in a randomized exercise clinical trial. Trials 2018;14:630. Trials. 2018; 19: 630.Published online 2018 Nov 14. doi: 10.1186/s13063-018-2958-z
Kittelson A, Hoogeboom TJ, Schenkman M, Stevens-Lapsley JE, van Meeteren NVL. Person-Centered Care and Physical Therapy: a “Patients-Like-Me” Approach. Phys Ther. In press
Mañago MM, Hebert JR, Kittelson J, Schenkman M. Feasibility of a targeted strengthening program to improve gait in people with Multiple sclerosis: A brief report. In J Rehabil Res 2018;41:364-367; doi: 10.1097/MRR.0000000000000306.; PMID:30044244
Mañago MM, Glick S, Hebert JR, Coote S, Schenkman M. Strength training to improve gait in people with MS:A critical review of exercise parameters and intervention approaches. Int J MS Care. 2019;21(2):47-56.
Manago MM, Hebert JR, Kittelson J, Schenkman M. Contributions of ankle, knee, hip, and trunk muscle function to gait performance in people with multiple sclerosis: A cross-sectional analysis.PTJ.2018;98:595-604
Hebert JR, Corboy JR, Vollmer T, Forster JE, Schenkman M. Efficacy of Balance and Eye-movement Exercises for Persons with Multiple Sclerosis (BEEMS).Neurology, 2018 Feb 27;90(9):e797-e807. doi: 10.1212/WNL.0000000000005013. Epub 2018 Jan 31.PMID: 29386274
Schenkman M, Moore CG, Kohrt WM, et al. Effect of High-intensity treadmill exercise on the motor symptoms in patients with de novo Parkinson’ disease. A phase 2 randomized clinical trial. JAMA Neurol. doi:10.1001/jamaneurol.2017.3517 Published online December 11, 2017.
Mañago M, Hebert J, Schenkman M. The psychometric properties of a clinical strength assessment protocol in people with multiple sclerosis. Int J MS Care 2017;19:253-262.
Myers K, Schenkman M. Utilizing a Curriculum Development Process to Design and Implement a New Integrated Clinical Education Experience. J PT Education 2017;31:71-82
Neumeier A, Nordon-Craft A, Malone D, Schenkman M, Clark B, Moss M. Prolonged acute care and post-acute care admission and recovery of physical function in survivors of acute respiratory failure: a secondary analysis of a randomized controlled trial. Crit Care. 2017;Jul 21;21(1).190. PMID: 28732512
Christiansen C, Moore C, Schenkman M, et al. Factors associated with ambulation with ambulatory activity in de novo Parkinson’s disease. J Neurol Phys Ther. 2017 Apr;41(2):93-100.
Akuthota V, Marshall BJ, Mintken PE, Schenkman M, Kumbhare DA. Second order peer reviews of clinically relevant articles for physiatrists. Physical therapy May not help acute lower back pain sufferers. Am J Phys Med Rehabil. 2017 Sep;96(9):682-685.doi: 1097/PHM.0000000000000676. [Epub ahead of print]
Mañago M, Schenkman M, Berliner J, Hebert J. Gaze Stabilization and Dynamic Visual Acuity in People with Multiple Sclerosis.J Vestibular Research 2016;26(5-6):469-477.
Kelmenson DA, Quan D, Nordon-Craft A, Malone D, Schenkman M, Moss M. Electrophysiological abnormalities can differentiate pre-hospital discharge functional status in critically ill patients with normal strength. Intensive Care Med, 2016 Sep;42(9):1504-5.
Moss M, Nordon-Craft A, Malone D, Van Pelt D, Kriekels W, Frankel SK, Warner ML, McNulty M, Faircloth D, Schenkman M.A Randomized Trial of an Intensive Physical Therapy Program for Acute Respiratory Failure Patients. Am J Respir Crit Care Med. 2016:193:1101-1110
Sotille P, Nordon-Craft A, Malone D, Luby D, Schenkman M, Moss M. Physical Therapist Treatment of Patients in the Neurological Intensive Care Unit: A Description of Practice, Phys Ther, 2015 Jul;95(7):1006-14. doi: 10.2522/ptj.20140112
Sottile PD, Nordon-Craft A, Malone D, Schenkman M, Moss M. Patient and family perceptions of physical therapy in the medical intensive care unit. J Crit Care. 2015 Oct;30(5):891-5. doi: 10.1016/j.jcrc.2015.04.119. Epub 2015 May 8. PubMed PMID: 26038155; PubMed Central PMCID: PMC4637256.
Malone D, Ridgeway K, Nordon-Craft A, Moss P, Schenkman M. Moss M. Physical therapist practice in the intensive care unit: Results of a national survey. Phys Ther 2015;95:1335-1344. Doi: 10.2522/ptj.20140417.
Olson AL, Swigris JJ, Gelkin A, Hannen L, Yagihashi K, Schenkman M, Grown KK.Physical functional capacity in idiopathic pulmonary fibrosis: Performance characteristic of the continuous-scale physical function performance test. Expert Review of Respiratory Medicine 2015;9:1-7
Rothlind JC, York MK, Carlson K, Luo P, Marks WJ Jr, Weaver FM, Stern M, Follett K, Reda D; CSP-468 Study Group. Neuropsychological changes following deep brain stimulation surgery for Parkinson’s disease: Comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):622-9. doi: 10.1136/jnnp-2014-308119. Epub 2014 Sep 2. PubMed PMID: 25185211.
Ellis R, Cress ME, Wood R, Schenkman M. Exploring the relationship between physical activity and participation in older adults with Parkinson’s disease. Topics in Geriatrics Rehabilitation, 2015;31:145-151
Gisbert R, Schenkman M.LEAP: Physical Intervention in Parkinson’s Disease. Phys Ther 2015;95(3):299-305.
Peer Reviewed Scientific and Professional Presentations
Rodriguez J, Schenkman M, Backstrom K.A Case Study and Pilot for developing and implementing the yearlong internship: Building a Sustainable Model of Clinical Education through an Academic and Clinical Partnership. Educational Leadership Conference, Baltimore, MD, October 2015
Non-Peer Reviewed Scientific and Professional Presentations
Schenkman M. Treatment for people with Parkinson’s disease, Parts I and II. Yamagata Prefectural University, Yamagata, Japan, May 25, 2017
Schenkman M.How to create high quality research in academic physical therapy. Invited keynote presentation, Annual Meeting of the Japan Physical therapy Association, Tokyo, Japan May 20, 2017.
Schenkman M. Exercise is important for those who live with Parkinson’s disease. 6th Annual Parkinson’s Symposium Life Care Center of Longmont. April 26, 2017
Schenkman M. Exercise is important for those who live with Parkinson’s disease. CU Movement Disorders, Third annual Parkinson’s disease symposium, October 1, 2016
Schenkman M. Why exercise and activity are important for living with Parkinson’s disease. Parkinson’s Association of the Rockies, September 26, 2015
Schenkman M. Exercise for people with PD. Community meeting, Boulder, CO June 6, 2015
Schenkman M. The effects of exercise on PD: Evidence and unanswered questions. Boulder PD Support Group; Boulder, CO, May 19, 2015
Schenkman M. Exercise and physical activity for people with PD. Movement Disorders Retreat, University of Colorado, May 5, 2015
Schenkman M. Exercise for people with Parkinson’s disease. Movement Disorders Conference, University of Colorado. Denver, CO. April 15, 2015
Schenkman M. Exercise for people with Parkinson’s disease. Parkinson’s Association of the Rockies Conference. Denver, CO. April 10, 2015
Schenkman M. The effects of exercise on PD: Evidence and unanswered questions. Parkinson’s Disease Foundation. Webinar, January 13, 2015
